SWG on Aging and Hematology
The SWG
The SWG
Key Points. CAR-T cell therapy demonstrates superior efficacy to bispecific antibody in DLBCL treatment, with higher complete response rates.CAR-T cell the
Chimeric Antigen Receptor-T (CAR-T) cell infusion is a rapidly evolving antitumor therapy; however, cardiovascular (CV) complications, likely associated with cytokine release syndrome (CRS) and systemic…
Un estudio prospectivo describe alteraciones ecocardiográficas tempranas en pacientes adultos con cánceres hematológicos tratados con esta modalidad terapéutica
Los pacientes en estudios de fase 3 o aquellos patrocinados por grandes compañías farmacéuticas parecen tener un mayor beneficio clínico
Open access journal of the Ferrata-Storti Foundation, a non-profit organization Open access journal of the Ferrata-Storti Foundation, a non-profit organization State Key Laboratory of Experimental…
Las áreas de actuación de ‘jóvenes hematólogos’ se centran en la formación, innovación y comunicación con el paciente
Using 4 illustrative cases, Treon and colleagues discuss their approach to therapy in patients with Waldenström macroglobulinemia (WM) based on genomic pro
Classical Hodgkin lymphoma is a lymphoproliferative disease with a good prognosis mainly seen in young people. Nevertheless secondary malignancy, cardiac disease and infertility may affect…
Aging Cell is an open access geroscience journal addressing the biology of aging, from molecular mechanisms of aging to age-related disease.
Tisagenlecleucel responses in patients with r/r FL remain highly durable a year after primary analysis; no new safety signals were observed.Low levels of L